Mendeleev Communications
RUS  ENG    JOURNALS   PEOPLE   ORGANISATIONS   CONFERENCES   SEMINARS   VIDEO LIBRARY   PACKAGE AMSBIB  
General information
Latest issue
Archive

Search papers
Search references

RSS
Latest issue
Current issues
Archive issues
What is RSS


Mendeleev Commun.:
Year:
Volume:
Issue:
Page:
Find




Personal entry:
Login:
Password:
Save password
Enter
Forgotten password?
Register

Mendeleev Communications, 2010, Volume 20, Issue 6, Pages 326–328
DOI: https://doi.org/10.1016/j.mencom.2010.11.008 (Mi mendc3081) 		 
This article is cited in 4 scientific papers (total in 4 papers)

Synthesis and properties of a folic acid–polyethylene glycol conjugate for systems intended for directed delivery of anticancer compounds

U. A. Budanova, O. O. Koloskova, Yu. L. Sebyakin

M.V. Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological University, Moscow, Russian Federation
Full-text PDF (1141 kB) Citations (4)
DOI: https://doi.org/10.1016/j.mencom.2010.11.008
Abstract: A conjugate of folic acid with a hydrophobic polyethylene glycol derivative has been synthesised; the characteristics of the resulting sterically-stabilised system based on lipodipeptides for directed delivery of doxorubicine have been determined.
Bibliographic databases:
Document Type: Article
Language: English


Citation: U. A. Budanova, O. O. Koloskova, Yu. L. Sebyakin, “Synthesis and properties of a folic acid–polyethylene glycol conjugate for systems intended for directed delivery of anticancer compounds”, Mendeleev Commun., 20:6 (2010), 326–328
Linking options:
  • https://www.mathnet.ru/eng/mendc3081
  • https://www.mathnet.ru/eng/mendc/v20/i6/p326
    • This publication is cited in the following 4 articles:
    Citing articles in Google Scholar: Russian citations, English citations
    Related articles in Google Scholar: Russian articles, English articles
    		Mendeleev Communications
     
      Contact us:
    		  Terms of Use  Registration to the website  Logotypes © Steklov Mathematical Institute RAS, 2025